Clinical Trials

Study Title:
An Open Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B Cell Malignancies (CLOVER 1) and Expansion Cohort in Patients with Waldenstrom Macroglobulinemia (CLOVER WaM)

For more information about the trial above please contact the study team:

Principal Investigator, Brian Hess, at

Study Coordinator, Sarah Britton, at, or please call +1 843-792-8057.

Trial opened at the following institutions: Medical University of South Carolina